INTEGER HOLDINGS CORPORATION (ITGR) Operating Margin
- Operating margin · 12 months: Value 9.70%; Formula and calculation Operating income / revenue. Period ending 2026-07-03..
Operating margin
Overview →Financial period ending 2026-07-03; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 9.70% | Operating income / revenue. Period ending 2026-07-03. $178.77M ÷ $1.84B × 100 ≈ 9.70% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 178.77M USD | Operating Income (Loss) |
| Revenue | 1.84B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 1.37B USD | Cost of Goods and Services Sold |
| Research and development | (m) | |
| Selling, general and administration | 224.07M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-07-03 | $178.77M | $1.84B | $1.37B | (m) | $224.07M | 9.70% |
| 2026-04-03 | $203.58M | $1.86B | $1.37B | (m) | $219.30M | 10.97% |
| 2025-12-31 | $221.26M | $1.85B | $1.35B | (m) | $211.75M | 11.94% |
| 2025-09-26 | $222.36M | $1.83B | $1.34B | (m) | $202.00M | 12.14% |
| 2025-06-27 | $223.93M | $1.79B | $1.31B | (m) | $196.37M | 12.48% |
| 2025-03-28 | $219.09M | $1.75B | $1.28B | (m) | $189.93M | 12.55% |
| 2024-12-31 | $208.24M | $1.72B | $1.26B | (m) | $185.20M | 12.13% |
| 2024-09-27 | $198.75M | $1.71B | $1.25B | (m) | $185.48M | 11.60% |
| 2024-06-28 | $186.05M | $1.67B | $1.22B | (m) | $181.95M | 11.15% |
| 2024-03-29 | $172.44M | $1.63B | $1.20B | (m) | $180.66M | 10.56% |
| 2023-12-31 | $167.33M | $1.60B | $1.18B | (m) | $175.62M | 10.48% |
| 2023-09-29 | $160.68M | $1.56B | $1.15B | (m) | $170.85M | 10.33% |
| 2023-06-30 | $141.87M | $1.49B | $1.11B | (m) | $166.94M | 9.50% |
| 2023-03-31 | $133.00M | $1.44B | $1.07B | (m) | $162.90M | 9.21% |
| 2022-12-31 | $121.33M | $1.38B | $1.02B | (m) | $160.58M | 8.82% |
| 2022-09-30 | $113.13M | $1.32B | $973.73M | (m) | $155.81M | 8.59% |
| 2022-07-01 | $116.96M | $1.28B | $941.47M | (m) | $151.88M | 9.14% |
| 2022-04-01 | $123.60M | $1.24B | $907.57M | (m) | $145.48M | 9.96% |
| 2021-12-31 | $135.71M | $1.22B | $884.11M | (m) | $141.42M | 11.11% |
| 2021-10-01 | $134.64M | $1.18B | $848.71M | (m) | $140.19M | 11.44% |
| 2021-07-02 | $141.31M | $1.11B | $803.02M | (m) | $109.53M | 12.76% |
| 2021-04-02 | $111.14M | (m) | $761.99M | (m) | $108.05M | (m) |
| 2020-12-31 | $120.61M | $1.07B | $787.74M | (m) | $109.01M | 11.24% |
| 2020-10-02 | $115.67M | $1.13B | $841.59M | (m) | $111.63M | 10.23% |
| 2020-07-03 | $122.39M | $1.20B | $873.78M | (m) | $140.96M | 10.22% |
| 2020-04-04 | (m) | $1.27B | (m) | (m) | (m) | (m) |
| 2020-04-03 | $162.54M | $1.27B | $908.74M | (m) | $140.20M | 12.78% |
| 2019-12-31 | $157.63M | $1.26B | $903.08M | (m) | $138.69M | 12.53% |
| 2019-09-27 | $174.68M | $1.24B | $868.07M | (m) | $136.18M | 14.14% |
| 2019-06-28 | $169.66M | $1.24B | $871.03M | (m) | $137.33M | 13.72% |
| 2019-03-29 | $164.68M | $1.24B | $869.52M | (m) | $140.97M | 13.31% |
| 2018-12-28 | $155.56M | $1.22B | $852.35M | (m) | $142.44M | 12.80% |
| 2018-09-28 | $159.51M | $1.54B | $1.13B | (m) | $163.87M | 10.36% |
| 2018-06-29 | $153.88M | $1.52B | $1.12B | (m) | $164.84M | 10.12% |
| 2018-03-30 | $147.61M | $1.50B | $1.10B | (m) | $163.31M | 9.85% |
| 2017-12-29 | $139.44M | $1.46B | $1.07B | (m) | $161.57M | 9.54% |
| 2017-09-29 | $135.92M | $1.43B | $1.05B | (m) | $156.47M | 9.50% |
| 2017-06-30 | $134.15M | $1.41B | $1.03B | (m) | $153.00M | 9.49% |
| 2017-03-31 | $123.68M | $1.40B | $1.02B | (m) | $150.90M | 8.83% |
| 2016-12-30 | $108.27M | $1.39B | $1.01B | (m) | $153.29M | 7.81% |
| 2016-09-30 | $66.79M | $1.34B | $986.21M | (m) | $149.29M | 4.97% |
| 2016-07-01 | $31.13M | $1.14B | $832.54M | (m) | $135.33M | 2.72% |
| 2016-04-01 | $14.89M | $971.33M | $697.13M | (m) | $121.81M | 1.53% |
| 2016-01-01 | $13.15M | $800.41M | $565.28M | (m) | $102.53M | 1.64% |
| 2015-10-02 | $41.03M | $652.57M | $433.36M | (m) | $93.87M | 6.29% |
| 2015-07-03 | $56.01M | $677.63M | $451.95M | (m) | $93.68M | 8.27% |
| 2015-04-03 | $62.52M | $674.83M | $448.63M | (m) | $91.46M | 9.26% |
| 2015-01-02 | $75.65M | $687.79M | $456.39M | (m) | $90.60M | 11.00% |
| 2014-10-03 | $71.11M | $694.68M | $463.11M | (m) | $89.95M | 10.24% |
| 2014-07-04 | $71.93M | $690.71M | $461.38M | (m) | $89.40M | 10.41% |
| 2014-04-04 | $69.52M | $689.96M | $461.80M | (m) | $89.77M | 10.08% |
| 2014-01-03 | $61.34M | $663.95M | $444.63M | (m) | $88.11M | 9.24% |
| 2013-09-27 | $49.88M | $646.51M | $432.71M | (m) | $84.85M | 7.72% |
| 2013-06-28 | $35.01M | $640.12M | $431.24M | (m) | $83.55M | 5.47% |
| 2013-03-29 | $28.96M | $635.34M | $431.83M | (m) | $82.05M | 4.56% |
| 2012-12-28 | $25.82M | $646.18M | $444.53M | (m) | $80.99M | 4.00% |
| 2012-09-28 | $36.96M | $628.74M | $434.29M | (m) | $78.62M | 5.88% |
| 2012-06-29 | $47.72M | $599.12M | $413.71M | (m) | $76.11M | 7.96% |
| 2012-03-30 | $54.93M | $579.09M | $399.02M | (m) | $72.93M | 9.49% |
| 2011-12-30 | $61.70M | $568.82M | $388.47M | (m) | $72.55M | 10.85% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-07-01 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-04-01 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $68.99M | $533.42M | $359.84M | (m) | $64.51M | 12.93% |
| 2010-10-01 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-07-02 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-01-01 | $1.05M | $521.82M | $355.40M | (m) | $70.29M | 0.20% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |